Differential effect of insulin-like growth factor-1 and growth hormone on hypothalamic regulation of growth hormone secretion in the rat

Journal of Endocrinological Investigation

Volumn 19, Issue 8, 1996, Pages 542-547

  Gil Ad, I ^a   Weizman, A ^a   Silbergeld, A ^a   Dickerman, Z ^a   Kaplan, B ^a   Laron, Z ^a   Koch, Y ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Autoregulation; GH; GHRH; IGF 1; Somatostatin

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SOMATOMEDIN C; SOMATOSTATIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HYPOTHALAMUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PULSATILE HORMONE RELEASE; RAT; SOMATOSTATIN RELEASE;

EID: 0029852184     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03349014     Document Type: Article

References (35)

1. Dieguez C., Page M.D., Scanlon M.F. Growth hormone neuroregulation and its alterations in disease states. Clin. Endocrinol. (Oxf.) 28: 109, 1988.
2. Martin J.B. The role of hypothalamic and extrahypothalamic structures in the control of GH secretion. In: Martin L., Ganong W.F. (Eds.), Frontiers in Neuroendocrinology. Raven Press, New York, 1976, p. 128.
3. Massara F., Camanni F. Effect of various adrenergic receptor stimulating and blocking agents on human GH secretion. J. Endocrinol. 54: 195, 1976.
4. Berelowitz M., Firestone S.L., Frohman L.A. Effect of GH excess and deficiency on hypothalamic somatostatin content and release and on tissue somatostatin distribution. Endocrinology 109: 714, 1981.
5. Tannenbaum G.S. Evidence for autoregulation of growth hormone secretion via the control of central nervous system. Endocrinology 107: 2117, 1980.
6. Berelowitz M., Szabo M., Frohman LA., Firestone S., Chu L., Hintz R.L. Somatomedin C mediates GH negative feedback by effects on both the hypothalamus and the pituitary. Science 212: 1279, 1981.
7. Lumpkin M.B., Negro-Vilar A., McCann S.M. Paradoxical elevation of GH by intraventricular somatostatin: possible ultrashort loop feedback. Endocrinology 116: 2070, 1985.
8. Murakami Y., Kato Y., Kabayama Y., Inoue T., Koshiyama H., Imura H. Involvement of hypothalamic growth hormone (GH) releasing factor in GH secretion induced by intracerebroventricular injection of somatostatin in rats. Endocrinology 120: 311, 1987.
9. Aguila M.C., McCann S.M. Stimulation of somatostatin release in vitro by synthetic growth hormone releasing factor by a non dopaminergic mechanism. Endocrinology 117: 762, 1985.
10. Nakamoto J.M., Gertner Y.M., Press M., Hintz R.L., Rosenfeld R.G., Genel M. Suppression of the growth hormone response to clonidine and GH releasing hormone by exogenous GH. J. Clin. Endocrinol. Metab. 62: 822, 1986.
11. Rosenthal S.M., Kaplan S.L., Grumbach M.M. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone induced GH secretion. A time-dependent effect. J. Clin. Endocrinol. Metab. 68: 1101, 1989.
12. Tannenbaum G.S., Guyda H., Posner B.I. Insulin like growth factors: a role in GH negative feedback and body weight regulation via brain. Science 220: 77, 1983.
13. Bermann M., Jaffe C.A., Friberg R.D., Barkan A. Negative feedback regulation of pulsatile growth hormone secretion by insulin like growth factor 1. J. Clin. Invest. 94: 138, 1994.
14. Pontiroli A.E., Lanzi R., Monti D.L., Sandoli A., Pozza G. Growth hormone autofeedback on GH response to GH releasing hormone. Role of fatty acids and somatostatin. J. Clin. Endocrinol. Metab. 72: 492, 1991.
15. Chalew S.A., Raiti S., Armour K.M., Kowarski A.A. Therapy in short children with subnormal integrated concentrations of growth hormone. Am. J. Dis. Child. 141: 195, 1987.
16. Laron Z., Klinger B., Erster B., Anin S. Effect of acute administration of insulin like growth factor in patients with Laron type dwarfism. Lancet 2: 1170, 1988.
17. Laron Z., Klinger B., Jensen L.T., Erster, B. Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism. Clin. Endocrinol. (Oxf.) 35: 145, 1991.
18. Koch Y., Baram T. Convenient procedure for extraction of gonadotropin-releasing hormone and thyrotropin-releasing hormone from hypothalamic tissue. FEBS Lett. 67: 186, 1976.
19. Gil-Ad I., Laron Z., Koch Y. Effect of acute and chronic administration of clonidine on hypothalamic content of growth hormone releasing hormone and somatostatin in the rat. J. Endocrinol. 131: 381, 1991.
20. Breier BH., Gallaher BW., Gluckman PD. Radioimmunoassay for insulin-like growth factor 1: some potential problems and pitfalls. J. Endocrinol. 128: 347, 1991.
21. Abe H., Motlich M.E., Van Wyk J.J., Underwood L.E. Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in normal rats. Endocrinology 113: 1319, 1983.
22. Spencer G.S.G., MacDonald A.A., Battle H.L., Moore L.G., Carlyle S.S. Intracerebral administration of insulin like growth factor I decreases circulating GH levels in the fetal pig. Acta Endocrinol. (Copenh.) 124: 563, 1991.
23. Arel Z., Tannenbaum G.S. Synergestic interaction between insulin like growth factor I and II and central regulation of pulsatile growth hormone secretion. Endocrinology 131: 758, 1992.
24. Spencer G.S., Bass J.J., Hodgkinson S.C., Edgley W.H., Moore L.G. Effect of intracerebroventricular injection of IGF-I on circulating GH concentration in the sheep. Domest. Anim. Endocrinol. 8: 155, 1991.
25. Laron Z., Klinger B., Erster B., Anin S. Effects of acute administration of insulin like growth factor I in patients with Laron-type dwarfism. Lancet II: 1170, 1988.
26. Willoughby J.O., Brogan M., Kapoor K. Hypothalamic interconnections of somatostatin and growth hormone releasing factor neurons. Neuroendocrinology 50: 584, 1989.
27. Zapf J., Hauri C., Waldvogel M., Froesch R. Acute metabolic effects and half lives of intravenously administered insulin like growth factor I and II in normal and hypophysectomized rats. J. Clin. Invest. 77: 1768, 1986.
28. Sheppard M., Kronheim S., Pimstone B.L. Stimulation by growth hormone of somatostatin release from rat hypothalamus in vitro. Clin. Endocrinol. (Oxf.) 9: 583, 1978.
29. Chihara K., Minamitani N., Kaje H., Arimura A., Fujita T. Intraventricular injected GH stimulates somatostatin release into rat hypophyseal portal blood. Endocrinology 169: 2279, 1981.
30. Sato M., Chihara K., Kita T., Kashio Y., Okimura Y., Kitajima N., Fujita T. Physiological role of somatostatin mediated autofeedback regulation for GH: importance of GH in triggering somatostatin release during a through period of pulsatile GH release in conscious male rats. Neuroendocrinology 50: 139, 1989.
31. Rogers K.V., Vician L., Steiner LA., Clifton D.K. The effect of hypophysectomy and GH administration on pre-prosomatostatin mRNA in the periventricular nucleus of the rat hypothalamus. Endocrinology 122: 586, 1988.
32. Domene H., Krishnamurthi K., Eshet R., Gil-Ad I., Laron Z, Koch I., Stannard B., Cassorla F., Roberts Ch.T. Jr., LeRoith D. Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding proteins-3, but not GH receptor gene expression in livers of juvenile rats. Endocrinology 133: 675, 1993.
33. Gurd W., Barrett ST., Tannenbaum G.S. The interrelationship of somatostatin (SRIF and growth hormone releasing factor (GRF) in mediation of growth hormone autofeedback. Program Ann. Meeting of Endocrine Society., Baltimore, USA, 1985, p. 58.
34. Katakami H., Downs T.R., Frohman L.A. Effect of hypophysectomy on hypothalamic growth hormone releasing factor content and release. Endocrinology 120: 1079, 1987.
35. Gil-Ad I., Eshet R., LeRoith D., Silbergeld A., Weizman A., Laron A., Koch Y. Effect of GH or IGF-I treatment on the regulation of growth and growth hormone secretion in intact and hypophysectomized rats. (Abstract) 7th Meeting Neuroendocrine Association, Jerusalem, Israel, October 1995.